Dr Reddy#39;s falls nearly 2% after co clarifies on NuvaRing-USFDA issue; Citi cuts target by 6.5%

Dr Reddy#39;s falls nearly 2% after co clarifies on NuvaRing-USFDA issue; Citi cuts target by 6.5% The USFDA sends the applicant a CRL if the agency determines that it will not approve the application, or ANDA, in its present form for one or more reason
This entry was posted in Global India, Market News, News. Bookmark the permalink.

Comments are closed.